Many things lead to the complex health condition called clinical obesity. Although the exact cause remains unknown, many factors can contribute to it. It's not just excess adiposity (too much body ...

Obesity is a growing health concern worldwide, affecting millions of people. It not only impacts physical appearance but also increases the risk of several chronic diseases, including diabetes, heart ...

China’s Harbour BioMed has launched a new biotech to develop bispecific antibodies focused on the holy grail of next-gen obesity meds—reducing body weight without losing muscle mass.

March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...

The GBD 2021 Adolescent BMI Collaborators concluded that global efforts over the past three decades have failed to adequately address the obesity crisis in children and adolescents. Consequently ...

Shares in Novo Nordisk fell on Monday on a second set of worse than expected trial results for the latest obesity drug from the manufacturer of blockbuster treatments Ozempic and Wegovy.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of the obesity programme at the world’s largest philanthropic organisation, the Novo Nordisk ...

LONDON/COPENHAGEN, March 10 (Reuters) - Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and ...

The International Journal of Obesity is a multi-disciplinary forum for research describing basic, clinical and applied studies in biochemistry, physiology, genetics and nutrition, molecular ...

(Relevance: India is suffering from the double burden of malnutrition and rising obesity. Recently, the Prime Minister also emphasized reducing oil consumption by 10%. He has nominated celebrities to ...